Targeting Childhood Brain Cancer
Read Michael’s StoryMichael Methner was diagnosed with glioma when he was 2. Today, thanks to research-driven advances in cancer science and medicine, he is a happy and energetic 10-year-old.
Reducing the Risk of Cancer Development
In the United States, 40 percent of all cancers are associated with modifiable risk factors.
Learn MoreAdvances in Treatment with Molecularly Targeted Therapy
Research-driven advances in identifying genetic mutations that fuel tumor growth have set the stage for a new era of precision medicine.
Learn MoreAdvances in Treatment with Immunotherapeutics
Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment.
Learn More
